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Despite the weak economy and more people lacking health insurance, the 
proportion of Americans reporting problems affording prescription drugs 
remained level between 2007 and 2010, with more than one in eight 
going without a prescribed drug in 2010, according to a new national study 
from the Center for Studying Health System Change (HSC). While remain-
ing stable overall, access to prescription drugs improved for working-age, 
uninsured people, likely reflecting a decline in visits to health care provid-
ers, as well as changes in the composition of the uninsured population. 
Likewise, elderly people eligible for both Medicare and Medicaid saw a 
sharp drop in prescription drug access problems. The most vulnerable 
people—the uninsured, those with low incomes, people in fair or poor 
health, and those with multiple chronic conditions—continued to face the 
most unmet prescription needs. For example, 48 percent of uninsured 
people in fair or poor health went without a prescription drug because of 
cost concerns in 2010, almost double the rate of insured people with the 
same reported health status.
DRUG AFFORDABILITY PROBLEMS STABILIZE
Prescription drug therapy is a critical component of treat-
ing many medical conditions. In 2010, two-thirds of all 
Americans—and nearly 90 percent of seniors—reported taking 
at least one prescription drug in the past year.1 Although phar-
maceutical spending growth has slowed in recent years, it still 
comprises more than 10 percent of total health care spending 
and is expected to accelerate in the coming years because of 
planned health coverage expansions and an aging population.2 
As a result, prescription drug affordability is a key concern 
among public and private payers, policy makers, and consum-
ers.
The proportion of Americans reporting problems affording 
prescription drugs remained unchanged at roughly 13 percent in 
both 2007 and 2010, according to findings from HSC’s nation-
ally representative 2010 Health Tracking Household Survey (see 
Table 1 and Data Source). This translates to approximately 39 
million Americans going without needed prescriptions because 
of cost concerns in 2010.
Given the large increase in the uninsured population—from 
42.8 million in 2007 to 51.7 million in 20103—and financial 
pressures caused by the severe economic recession and sluggish 
recovery, it is somewhat surprising that drug affordability prob-
lems did not increase. The level trend in affordability problems 
may be a byproduct of reductions in medical care in response to 
the weak economy—fewer physician visits may have led to fewer 
prescriptions being written. At the same time, loss of patent 
protection for several major branded drugs and additional shifts 
toward generic use, as well as lower generic prices, also likely 
made some prescriptions more affordable for patients.  
While access to prescription drugs remained stable in 
recent years, the number and percentage of Americans report-
ing unmet prescription drug needs because of cost concerns 
remained significantly  higher in 2010 compared to 2003 (13% 
vs. 10%), largely reflecting an increase in access problems for 
children and working-age adults (aged 19-64) between 2003 and 
2007.4
  TABLE 1: Changes in Americans Reporting Unmet Prescription 
Drug Needs Because of Cost Concerns, by Type of 
Insurance Coverage, 2003-2010
2003 2007 2010
All Persons 10.2% 13.1%# 13.0%#
Medicare Beneficiaries Aged >65 8.9 8.2 8.4
Medicare Beneficiaries Aged <65 29.5 27.2 30.6
Working-Age Adults (Aged 19 to 64) 13.8 18.1# 17.4#
Private Insurance 8.9 11.2# 9.8
Medicaid/Other State Coverage 22.9 25.9 22.9
Uninsured 26.3 35.9# 29.4*
Children (Aged 0 to 18) 3.1 5.0# 5.8#
Private Insurance 2.2 2.4 4.2#
Medicaid/Other State Coverage 3.4 6.8 5.9
Uninsured 9.7 13.2 14.2
Note: Children and working-age adults with other health insurance, such as military or veterans 
coverage, are omitted because of insufficient sample size.
* Change from 2007 is statistically significant at p<.05.
# Change from 2003 is statistically significant at p<.05.
Sources: HSC 2003 Community Tracking Study Household Survey and HSC 2007 and 2010 
Health Tracking Household Surveys
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Data Source
This Tracking Report presents findings from the HSC 2010 and 2007 Health Tracking 
Household Surveys and the 2003 Community Tracking Study Household Survey. 
All three telephone surveys used nationally representative samples of the civilian, 
noninstitutionalized population. For the first time, the 2010 survey included a cell 
phone sample because of declining percentages of households with landline phones. 
Sample sizes include about 47,000 people for the 2003 survey, about 18,000 
people for the 2007 and about 17,000 people for the 2010 survey. Response rates 
for the surveys were 57 percent in 2003, 43 percent in 2007, and 46 and 29 
percent, respectively, for the landline and cell phone samples in 2010. Population 
weights adjust for probability of selection and differences in nonresponse based on 
age, sex, race or ethnicity, and education. The weights also adjust for the increased 
probability of selection in cases of households using both landline and cell phones. 
Although all three surveys are nationally representative, the sample for the 2003 
survey was largely clustered in 60 representative communities, while the 2007 and 
2010 surveys were based on a stratified random sample of the nation. Standard 
errors account for the complex sample design of the surveys. Questionnaire design, 
survey administration and the question wording of all measures in this study were 
similar across the three surveys. 
Estimates of unmet need for prescription drugs were based on the following 
question: “During the past 12 months, was there any time you needed prescription 
medicines but didn’t get them because you couldn’t afford it?” Insurance status 
reflects coverage on the day of the interview and includes coverage obtained 
through employer-sponsored and individually purchased private insurance, 
Medicare, Medicaid, the Children’s Health Insurance Program, other state programs, 
TRICARE and other military insurance programs, and the Indian Health Service.
ACCESS PROBLEMS VARY BY INSURANCE COVERAGE
Insurance coverage remained strongly related to a person’s ability 
to afford prescription drugs. Individuals with private insurance 
experienced relatively few problems, with 9.8 percent of work-
ing-age adults and 4.2 percent of children reporting an unmet 
prescription need in 2010. Overall, about 95 percent of people 
with private insurance indicated that they had prescription drug 
coverage in 2010 (findings not shown).
In contrast, uninsured people continued to have the most 
problems affording prescription drugs. Overall, 27.4 percent of 
uninsured people reported prescription drug access problems 
in 2010, or nearly three times the rate for insured people (see 
Figure 1). Access for the uninsured differed across age groups: 
about one in seven uninsured children and three in 10 uninsured 
working-age adults went without a prescription drug because 
of cost concerns. The uninsured face the highest exposure to 
drug costs because they typically must pay full retail price for 
prescriptions. Older research indicates that people without drug 
coverage have paid 15 percent to 20 percent more for commonly 
prescribed drugs than those with coverage.5 However, more 
recently, pharmaceutical companies, as well as state and local 
governments, have implemented programs to make prescription 
drugs more affordable for low-income people.
Access to prescription drugs among Medicare beneficiaries 
varied significantly by eligibility status. As in previous years, 
nonelderly Medicare beneficiaries, whose eligibility is based 
on permanent disability or severe kidney disease, fared worse 
than beneficiaries aged 65 and older. This difference in access 
problems likely reflects nonelderly Medicare beneficiaries’ more 
complex medical and pharmacological needs and lower incomes. 
In 2010, nonelderly Medicare beneficiaries were 3.6 times as 
likely to report an unmet prescription drug need as their elderly 
counterparts. 
PRESCRIPTION ACCESS IMPROVES FOR THE 
UNINSURED…
While prescription drug access remained stable for most 
Americans in recent years, uninsured, working-age adults saw a 
significant decrease in unmet prescription drug needs, from 35.9 
percent in 2007 to 29.4 percent in 2010. Some portion of the 
decrease in access problems likely reflects that fewer uninsured 
people reported visiting a health care provider in 2010 compared 
with 2007.6 As a result, they were less likely to have the opportu-
nity to have any medications prescribed.  
Changes in the composition of the uninsured population 
also may have contributed to the improvement in prescription 
drug access for this group. Other research shows that the growth 
in the uninsured population between 2007 and 2010 occurred 
primarily among people who are healthier and have higher 
incomes, factors that are associated with fewer prescription drug 
access problems.7 However, further analysis shows that after 
accounting for changes in the health status, income, and other 
characteristics of the uninsured population, most of the decrease 
in prescription drug access problems among the uninsured 
remained.8
Figure 1: Americans Reporting Unmet Prescription Drug Needs 
Because of Cost Concerns, by Insurance Status, 
2007-2010
Sources: HSC 2007 and 2010 Health Tracking Household Surveys
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…AND FOR DUALLY ELIGIBLE SENIORS
Another notable departure from the stable trend occurred 
among elderly people who are eligible for both Medicare and 
Medicaid coverage. After doubling between 2003 and 2007, 
unmet prescription drug needs for dually eligible, elderly 
Medicare beneficiaries dropped sharply from 21.7 percent in 
2007 to 8.0 percent in 2010 (findings not shown). 
Administration of dually eligible beneficiaries’ drug plans 
shifted from Medicaid to Medicare Part D in January 2006. An 
earlier HSC study noted that lingering transition problems, such 
as coverage lapses and overcharging for some medications, may 
have contributed to the rise in access problems in 2007.9 The 
return to pre-implementation levels in 2010 likely reflects efforts 
by the Centers for Medicare and Medicaid Services to resolve 
transition-related obstacles. These measures included imple-
menting prospective enrollment of new dual eligibles to avoid 
coverage gaps and temporary coverage of existing prescriptions 
to ensure uninterrupted therapy for new enrollees, allowing 
time for them to switch to a covered drug or obtain a formulary 
exception.10
LOW INCOME, SICKER FARE WORSE
Unmet prescription drug needs were greater for people with the 
lowest incomes. In 2010, individuals with incomes below 200 
percent of poverty—$44,100 for a family of four—were 3.4 times 
more likely to report drug access problems as those earning 
400 percent of poverty or more (19.3% vs. 5.7%) (see Table 2). 
Unmet prescription drug needs remained steady for each income 
group overall between 2007 and 2010 but were still elevated 
compared with 2003 levels.
People who reported being in fair or poor health also were 
more likely to have gone without a prescription medication 
because of cost concerns (see Table 3). They were more than 
three times likelier to report a drug affordability problem com-
pared with those in good, very good or excellent health (31.2% 
v. 9.7%). Less-healthy people were more likely to report having 
taken a prescription medication in the past year compared with 
healthier people (82.1% vs. 63.1%) and, therefore, had more 
opportunities to encounter a problem affording a medication 
(findings not shown). Uninsured people in fair or poor health 
had the most problems, with 48 percent reporting an unmet pre-
scription need in 2010, almost double the rate of insured persons 
with the same reported health status. 
Patients with multiple chronic conditions were more than 
twice as likely to go without a needed prescription as people 
without a chronic condition (24.4% vs. 11.6%). As with health 
status, prescription usage—and the risk of an affordability prob-
lem—increased with disease burden: 98 percent of people with 
multiple chronic conditions reported taking a prescription in the 
past year, compared with 53 percent of those without a chronic 
condition (findings not shown). Uninsured people with mul-
tiple chronic conditions were the most vulnerable population: 69 
percent reported an unmet prescription need because of cost in 
2010, compared with 20 percent of insured people with multiple 
chronic conditions. 
IMPLICATIONS
Despite the weak economy, high unemployment and more 
uninsured Americans, reports of prescription drug affordability 
problems remained stable in recent years. Part of this may be 
a byproduct of decreased demand for medical care, especially 
among the uninsured. Also, trends in the pharmaceutical indus-
try, including patent expirations and expanded use of existing 
generic drugs, may have helped increase the affordability of 
prescriptions for some. Since 2007, several major branded drugs 
such as Depakote—for treatment of seizures, bipolar disorder 
and migraine headaches—and Norvasc—for high-blood pressure 
and chest pain—lost patent protection and became available in 
generic form. Total generic market share grew from 67 percent in 
2007 to 78 percent in 2010, and spending on new brands—drugs 
launched in the previous 24 months—declined from $10 billion 
in 2007 to $4 billion in 2010.11 
Another factor that likely improved drug access during this 
period was the growth in low-cost generic programs offered by 
many retail pharmacy chains. A selection of discount generics—
as low as $4 for a month’s supply—provided by big-box stores 
and many retail pharmacy chains has increased the affordability 
  TABLE 2: Changes in Americans' Unmet Prescription Drug Needs 
Because of Cost Concerns, by Income, 2003-2010
2003 2007 2010
All Persons 10.2% 13.1%# 13.0%#
Insured 8.1 10.0# 10.1#
Uninsured 23.5 31.8# 27.4#
Income
<200% Federal Poverty Level (FPL) 16.6 20.4# 19.3#
Insured 13.9 15.5 16.0
Uninsured 25.4 34.3# 28.9
200 to <400% FPL 9.5 13.1# 13.3#
Insured 8.1 11.1# 10.6#
Uninsured 20.5 28.4# 26.7
400%+ FPL 4.7 6.5# 5.7#
Insured 3.8 5.5# 4.5
Uninsured 20.9 26.0 22.0
Note: Differences between the insured and uninsured within each category are statistically 
significant at p<.05.
* Change from 2007 is statistically significant at p<.05.
# Change from 2003 is statistically significant at p<.05.
Sources: HSC 2003 Community Tracking Study Household Survey and HSC 2007 and 2010 
Health Tracking Household Surveys
of many medications.12 Efforts by health insurers—such as zero 
or reduced copayments for generic drugs and step therapy, where 
a generic must be tried first—also have encouraged generic use.
Moreover, pharmaceutical companies, state and local govern-
ments, and other organizations have contributed to the avail-
ability of prescription drugs for uninsured persons through 
prescription assistance programs that offer eligible patients access 
to brand-name and generic medications at little or no cost.13 
These programs have grown in recent years, with the National 
Conference of State Legislatures reporting that the number 
of states offering financial assistance for prescription drugs 
increased from 26 in 2006 to 42 in 2009. In addition, more states 
are purchasing medications in bulk directly from manufacturers 
and distributing them at a discount to low-income and uninsured 
patients.14 
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Although prescription drug coverage is 
an 'essential benefit' to be provided by 
health plans participating in the state 
health insurance exchanges, flexibility 
in plan design leaves room for benefit 
limits, including patient cost sharing, 
prior authorization, preferred drug lists, 
dispensing limits and other utilization 
management tools, that may affect gains 
in access.
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  TABLE 3: Changes in Americans' Unmet Prescription Drug Needs 
Because of Cost Concerns, by Health Status and 
Chronic Conditions, 2003-2010
2003 2007 2010
All Persons 10.2% 13.1%# 13.0%#
Insured 8.1 10.0# 10.1#
Uninsured 23.5 31.8# 27.4#
Health Status
Excellent, Very Good or Good 7.6 9.7# 9.7#
Insured 6.0 7.8# 7.6#
Uninsured 19.0 23.4 21.5
Fair or Poor 26.1 30.6# 31.2#
Insured 22.5 23.4 25.9#
Uninsured 41.6 52.8# 48.0
Number of Chronic Conditions1
Zero 9.2 12.3# 11.6#
Insured 6.5 8.3# 8.2#
Uninsured 20.0 27.2# 21.2*
One 16.5 18.7 18.9
Insured 13.2 13.5 14.4
Uninsured 47.1 59.1# 49.3
Two+ 21.0 25.3# 24.4#
Insured 19.0 22.1 20.1
Uninsured 58.5 67.1 69.1
Note: Differences between the insured and uninsured within each category are statistically 
significant at p<.05.
1 Chronic conditions included diabetes, arthritis, asthma, chronic obstructive pulmonary disease 
(COPD), hypertension, heart disease, cancer (excluding skin cancer), benign prostate disease or 
depression. The number of chronic conditions equals the number of these diseases for which the 
respondent reported having received treatment during the past two years.
* Change from 2007 is statistically significant at p<.05.
# Change from 2003 is statistically significant at p<.05.
Sources: HSC 2003 Community Tracking Study Household Survey and HSC 2007 and 2010 
Health Tracking Household Surveys
Over the next several years, generic formulations of other 
blockbuster drugs—including the two most widely sold drugs in 
the world, Lipitor to treat high cholesterol and Plavix to reduce 
the risk of stroke and heart attack by preventing blood clots—are 
scheduled to become available. This likely will help improve 
the affordability of prescription medications. At the same time, 
increases in the cost and utilization of expensive biologic and 
other specialty drugs will likely add to cost concerns among 
certain patients with serious health conditions. Specialty drugs 
represent the fastest-growing segment of drug spending and are 
expected to comprise 40 percent of U.S. drug spending by 2014.15 
In 2014, the 2010 Patient Protection and Affordable Care 
Act (PPACA) is expected to extend prescription drug coverage 
to tens of millions of uninsured Americans via expansions in 
Medicaid eligibility and subsidized private coverage in health 
insurance exchanges. Although prescription drug coverage is an 
“essential benefit” to be provided by health plans participating 
in the state health insurance exchanges, flexibility in plan design 
leaves room for benefit limits, including patient cost sharing, 
prior authorization, preferred drug lists, dispensing limits and 
other utilization management tools, that may affect gains in 
access.
Similarly, while all states provide prescription coverage under 
Medicaid, it is an optional benefit that is limited by cost-contain-
ment strategies in some states. An earlier HSC study discussed 
a variety of such policies employed by state Medicaid programs, 
such as use of prior authorization, limits on the number of pre-
scriptions, higher patient cost sharing and mandatory generic 
substitution.16 Medicaid enrollees in states that had implemented 
the most aggressive policies reported greater problems accessing 
prescription medications. Amidst ongoing state budget prob-
lems, use of these strategies is likely to continue to pose chal-
lenges for Medicaid patients needing prescription drugs. 
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Other elements of PPACA may affect the affordability of pre-
scription medications as well. Currently, Medicare Part D enroll-
ees experience more access problems compared to those with 
supplemental private coverage, in part because of the “doughnut 
hole” coverage gap, where beneficiaries are responsible for the 
full cost of their prescription drugs out of pocket. Health care 
reform aims to close the coverage gap by incrementally reducing 
beneficiaries’ out-of-pocket share until it reaches 25 percent in 
2020.  
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